Home
The power of specialized thinking.
  • Home
  • Practices
    • Health PR
    • Financial Services PR
    • Tech + Energy Markets PR
    • Branding + Interactive
    • Professional Services PR
    • Investor Relations
  • Clients
    • Health PR
    • Financial Services PR
    • Tech + Energy Markets PR
    • Branding + Interactive
    • Professional Services PR
    • Investor Relations
  • Why Makovsky?
  • Blog
  • Industry Issues
  • News
  • Careers
  • About Us
News > In The News > Oncology Review and Outlook

Oncology Review and Outlook

Oncology Products Pipeline Loaded With Potential Blockbusters

SPECIAL REPORT 2010

"Biomarkers are chemical, physical or biological parameters to indicate disease states," says Gil Bashe, executive VP of the Health practice at Makovsky + Co. Oncology biomarkers facilitate high-speed, non-invasive cancer diagnosis; and can enhance early cancer detection and screening.  “The demand for oncology biomarkers is increasing as their ability to trace the exact type of cancer and target patient-specific molecular structure is evident,” he says. ...

Download the full report here

Article Tools

Printer-friendly versionSend to friendPDF version
16 East 34th Street, New York, NY 10016   |   T. 212.508.9600   |   F. 212.751.9710   |   info@makovsky.com
© 2009 Makovsky + Company